Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient Use of Ivermectin in COVID-19
NCT04530474Phase 3Withdrawn
- Sponsor
- Temple University
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Temple University. Planned start Apr 2021; status: withdrawn.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04530474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530474.